Acumen Pharmaceuticals (ABOS) Revenue & Revenue Breakdown
Acumen Pharmaceuticals Revenue Highlights
00
Acumen Pharmaceuticals Revenue by Period
Acumen Pharmaceuticals Revenue by Year
Date | Revenue | Change |
---|---|---|
2024-12-31 | - | 100.00% |
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | -100.00% |
2020-12-31 | $1.44M | -15.38% |
2019-12-31 | $1.70M | - |
Acumen Pharmaceuticals generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Acumen Pharmaceuticals Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2025-06-30 | - | 100.00% |
2025-03-31 | - | -100.00% |
2024-12-31 | $178.00K | 100.00% |
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $290.00K | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | -100.00% |
2020-12-31 | $1.44M | 96.71% |
2020-09-30 | $730.00K | 383.44% |
2020-06-30 | $151.00K | -33.19% |
2020-03-31 | $226.00K | - |
Acumen Pharmaceuticals generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Acumen Pharmaceuticals Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
AGEN | Agenus | $103.46M | $25.69M |
ZNTL | Zentalis Pharmaceuticals | $67.42M | - |
IRD | Opus Genetics | $10.99M | $4.37M |
IMDX | Insight Molecular Diagnostics | $1.88M | $518.00K |
ADVM | Adverum Bio | $1.00M | - |
GUTS | Fractyl Health | $120.00K | - |
ALXO | ALX Oncology | - | - |
INO | Inovio Pharmaceuticals | - | - |
PRLD | Prelude Therapeutics | - | $4.00M |
ABOS | Acumen Pharmaceuticals | - | - |
IMUX | Immunic | - | - |